Bright Peak Therapeutics
Drug DiscoveryWebsite
Bright Peak Therapeutics valuation and funding history | Last updated: June 11, 2024 | 2 funding rounds
Current Valuation
N/A
As of June 11, 2024
Total Funding Raised
$244.0M
Across 2 rounds
Last Round
Later Stage VC
$90.0M
Last Funding
Jun 2024
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| June 11, 2024 | Later Stage VC (Series C) | $90.0M | N/A | - |
| June 10, 2021 | Early Stage VC (Series B) | $107.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Bright Peak Therapeutics is currently valued at N/A as of June 11, 2024. The company has raised a total of $244.0M in funding across 2 funding rounds.
Explore More Data
Detailed analysis for Bright Peak Therapeutics
What is Bright Peak Therapeutics Worth in 2026?
Bright Peak Therapeutics is a leading private company in the Drug Discovery sector. Track Bright Peak Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Bright Peak Therapeutics Valuation is Determined
Private company valuations like Bright Peak Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.